No Added Benefit on the Composite Primary End-Point with the Higher Dose When Entire ACS Study Population Considered Important New Findings with Higher Loading Dose of PLAVIX(R) for Heart Patients Undergoing Coronary Angioplasty (PCI) PARIS & PRINCET…
Biopharmaceuticals, Interventional Cardiology
Bristol-Myers Squibb, sanofi-aventis, Plavix, clopidogrel

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “New Large-Scale, Global Study Provides Additional Information About an Intensified Dose-Regimen of Plavix(R) in Acute Coronary Syndrome Patients Undergoing Angioplasty”
Leave a Comment